DOC vs PSA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

DOC

51.5
AI Score
VS
DOC Wins

PSA

28.4
AI Score

Investment Advisor Scores

DOC

Nov 11, 2026
52score
Recommendation
HOLD

PSA

Nov 11, 2026
28score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric DOC PSA Winner
Forward P/E 169.4915 31.746 PSA
PEG Ratio 4.0809 4.518 DOC
Revenue Growth 16.3% 10.8% DOC
Earnings Growth 68.2% -35.4% DOC
Tradestie Score 51.5/100 28.4/100 DOC
Profit Margin 12.3% 37.7% PSA
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

DOC 1M: +7.7% · 3M: -1.2% PSA 1M: +16.3% · 3M: +3.8%

Current Technical Phase

DOC

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.4 · Price: $20.41

PSA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 70

RSI (14): 70.1 · Price: $335.93

Fundamentals Snapshot

Metric DOC PSA
Market Cap — —
Forward P/E 145.8 36.3
Trailing P/E 37.5 35.6
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.6% 0.7%
Operating Margin 0.1% 0.4%
EPS 0.55 9.51
Dividend Yield 0.06% 0.04%

Frequently Asked Questions

Based on our detailed analysis, DOC is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.